These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9421280)

  • 1. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice.
    Hunter JC; Fontana DJ; Hedley LR; Jasper JR; Lewis R; Link RE; Secchi R; Sutton J; Eglen RM
    Br J Pharmacol; 1997 Dec; 122(7):1339-44. PubMed ID: 9421280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype.
    Paris A; Mantz J; Tonner PH; Hein L; Brede M; Gressens P
    Anesth Analg; 2006 Feb; 102(2):456-61. PubMed ID: 16428542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens.
    Ihalainen JA; Tanila H
    J Neurochem; 2004 Oct; 91(1):49-56. PubMed ID: 15379886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on diurnal intraocular pressure variation of eliminating the alpha-2 adrenergic receptor subtypes in the mouse.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):929-33. PubMed ID: 18326714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
    Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
    Bhalla S; Ali I; Andurkar SV; Gulati A
    Eur J Pharmacol; 2013 Sep; 715(1-3):328-36. PubMed ID: 23712005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of alpha 2-adrenoceptors in the modulation of the thermoregulatory response in mice induced by meperidine.
    Höcker J; Paris A; Scholz J; Tonner PH; Nielsen M; Bein B
    Anesthesiology; 2008 Jul; 109(1):95-100. PubMed ID: 18580178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2C adrenoceptor subtypes in mice.
    Guo TZ; Davies MF; Kingery WS; Patterson AJ; Limbird LE; Maze M
    Anesthesiology; 1999 Feb; 90(2):470-6. PubMed ID: 9952154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors.
    Szot P; Lester M; Laughlin ML; Palmiter RD; Liles LC; Weinshenker D
    Neuroscience; 2004; 126(3):795-803. PubMed ID: 15183527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype.
    Brady AE; Wang Q; Allen PB; Rizzo M; Greengard P; Limbird LE
    Mol Pharmacol; 2005 May; 67(5):1690-6. PubMed ID: 15705742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antiaggressive effect of an alpha-2 adrenoceptor agonist naphthylmedetomidine in mice.
    Votava M; Hess L; Krsiak M
    Aggress Behav; 2008; 34(4):394-403. PubMed ID: 18348168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
    Trendelenburg AU; Klebroff W; Hein L; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of central and peripheral alpha2-adrenoceptor subtypes in gastric mucosal defense in the rat.
    Gyires K; Zádori ZS; Shujaa N; Minorics R; Falkay G; Mátyus P
    Neurochem Int; 2007 Oct; 51(5):289-96. PubMed ID: 17707950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice.
    Fagerholm V; Grönroos T; Marjamäki P; Viljanen T; Scheinin M; Haaparanta M
    Eur J Pharmacol; 2004 Nov; 505(1-3):243-52. PubMed ID: 15556159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
    Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
    J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene.
    Ozdoğan UK; Lähdesmäki J; Scheinin M
    Eur J Pharmacol; 2006 Jan; 529(1-3):105-13. PubMed ID: 16325800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.